Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-02 Sale | 2024-02-05 9:24 pm | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 8,056 | $47.34 | $381,411 | 58,154 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Tax Withholding | 2024-04-03 4:01 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 1,824 | $47.62 | 56,330 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 9:06 pm | N/A 2034-01-03 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 101,445 | $0 | 141,210 (Direct) | View |
| 2024-01-05 Tax Withholding | 2024-01-08 9:06 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 2,507 | $37.96 | 141,210 (Direct) | View |
| 2024-01-08 Tax Withholding | 2024-01-08 9:06 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 1,449 | $41.53 | 141,210 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-05 4:46 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 1,375 | $25.25 | 43,721 (Direct) | View |
| 2023-01-05 Option Award | 2023-01-09 5:00 pm | N/A 2033-01-05 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 92,663 | $0 | 115,096 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-09 5:00 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 1,665 | $27.52 | 115,096 (Direct) | View |
| 2022-10-11 Option Award | 2022-10-13 4:03 pm | N/A 2032-10-11 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 100,000 | $0 | 124,098 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-10-13 4:03 pm | N/A N/A | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 1,464 | $56.9 | 124,098 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:23 pm | N/A 2032-01-06 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 53,772 | $0 | 66,272 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-01 5:37 pm | N/A 2031-04-01 | SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer | 104,500 | $0 | 104,500 (Direct) | View |